MDxHealth Shareholder Transparency Declaration
NEWS RELEASE – REGULATED INFORMATION 10 December 2021, 23:55 CET MDxHealth Shareholder Transparency Declaration IRVINE, CA, and HERSTAL, BELGIUM –...
News
[Updated] Quad M dramatically increases its employees utilizing its staffing solution Company continues its asymptotic revenue growth
EDGEWATER, N.J., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Joseph Frontiere, CEO of Quad M Solutions, Inc. said “Quad M Solutions...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early...
Psychemedics Corporation Declares Cash Dividend
ACTON, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs...
The Governance Institute Releases 2021 National Survey of Healthcare Governance
Boards have made small advances in diversity; less time is spent on strategic planningLINCOLN, Neb., Dec. 10, 2021 (GLOBE NEWSWIRE)...
Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2021
Monthly information regarding the total number of voting rights and total number of shares of the Company as of November...
Adicet Bio, Inc. Announces Closing of $100 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
MENLO PARK, Calif. and BOSTON, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company...
CytoDyn to Hold Webcast and Live Q/A on December 14
VANCOUVER, Washington, Dec. 10, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company...
Quad M dramatically increases its employees utilizing its staffing solution Company continues its asymptomatic revenue growth
EDGEWATER, N.J., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Joseph Frontiere, CEO of Quad M Solutions, Inc. said “Quad M Solutions...
Todos Medical Interview and Presentation on Benzinga’s All Access Conference Live December 14th at 10:20 AM EST
New York, NY, and Tel Aviv, ISRAEL, Dec. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a...
Monthly information related to total number of voting rights and shares composing the share capital – November 30, 2021
Monthly information related to total number of voting rights and shares composing...
Cingulate Inc. Announces Closing of Initial Public Offering
KANSAS CITY, Kan., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Cingulate Inc. (“Cingulate” or the “Company”), a clinical-stage biopharmaceutical company utilizing...
Praxis Precision Medicines to Host Movement Disorder Day on December 17, 2021
BOSTON, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...
TIPS ANNOUNCES ACQUISITION TARGET, CAMBRIDGE ORTHOPAEDIC LABS
$TIPS ANNOUNCES ACQUISITION TARGET, CAMBRIDGE ORTHOPAEDIC LABS Cambridge Orthopaedic Labs Ltd $TIPS ANNOUNCES ACQUISITION TARGET, CAMBRIDGE ORTHOPAEDIC LABS Cambridge Orthopaedic...
Junshi Biosciences Announces NMPA Accepted supplemental New Drug Application for Toripalimab in Combination with Chemotherapy as First-Line Treatment of Advanced NSCLC
6th indication for toripalimab submitted in ChinaSHANGHAI, China, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877; SSE: 688180),...
22nd Century Ready to Provide Full Commercial Support to New Zealand’s Plan to Reduce Nicotine Content of All Cigarettes
New Zealand Ministry of Health announced aggressive measures to reduce smoking, including a reduced nicotine mandate by 202522nd Century fully...
StageZero Life Sciences, Ltd Announces Appointment of SRCO as Auditors
TORONTO, ON and RICHMOND, VA / ACCESSWIRE / December 10, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the...
Poko Innovations Inc. Announces Grant of Options and Entering into Shares for Debt Agreements
Not for distribution to U.S. Newswire Services nor for dissemination in the United States. Any failure to comply with this...
ModMed® Wins Prestigious 2021 Company of the Year BIG Award for Business
The Company of the Year award recognizes extraordinary achievements and business leadership based on voting by experienced business executives. BOCA...
Celcuity Presents Updated Results of Phase 1b Study of Gedatolisib in Combination with Palbociclib and Endocrine Therapy for ER+ Advanced Breast Cancer (ABC) at the 2021 San Antonio Breast Cancer Symposium
78% ORR in 3rd line patients and 63% ORR overall in patients treated with three weeks on/one week off gedatolisib...